Protocol COMIRB Number: 04-0205
**************************
PURPOSE OF THIS RESEARCH
To test the safety and efficacy of a novel drug (Botox) for the treatment of obstructive lower urinary symptoms due to benign prostatic hyperplasia.
WHO CAN TAKE PART?
To be eligible for this study you need to have lower urinary symptoms related to benign enlargement of the prostate including one or more of the following symptoms:
• Weak Urinary Stream or Straining
• Urinary Urgency or Frequency
• Multiple Nightly Awaking Form Sleep To Empty Your Bladder
We will provide the drug free of charge. Treatment procedure, preliminary and follow-up tests including physician appointment are also provided at no cost to you.
YOU WILL NOT BE PAID FOR TAKING PART IN THIS STUDY.
Contact us